ANEB Anebulo Pharmaceuticals
- 2.770
- -0.080-2.81%
Anebulo Pharmaceuticals News
Anebulo Pharmaceuticals | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Cundy Kenneth C
Anebulo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Cundy Kenneth C
Anebulo Pharmaceuticals | 10-Q: Quarterly report
Anebulo Pharmaceuticals | 8-K: Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2024 Financial Results and Recent Updates
Anebulo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director English Aron R.
Anebulo Pharmaceuticals | 8-K: Current report
Anebulo Pharmaceuticals: Q1 2024 Earnings Report
Anebulo Pharmaceuticals | 8-K: Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2024 Financial Results and Recent Updates
Anebulo Pharmaceuticals | ARS: Annual Report to Security Holders
Anebulo Pharmaceuticals | DEF 14A: Definitive information statements
Anebulo Pharmaceuticals | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Anebulo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Cunningham, Richard Anthony
Anebulo Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Chief Executive Officer Cunningham, Richard Anthony
Anebulo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SHAH BIMAL R.
Anebulo Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director SHAH BIMAL R.
Anebulo Pharmaceuticals | 8-K: Current report
Anebulo Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Chief Financial Officer George Dan
Anebulo Pharmaceuticals | 8-K: Current report
Anebulo Pharmaceuticals | 10-K: FY2023 Annual Report
Anebulo Pharmaceuticals | 8-K: Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Recent Updates
Analysis
Price Target
No Data
